Orion Metals获颁今年第四块矿权租地

2013-03-23 14:15:48 来源：澳华财经在线 编辑：杨欣

ACB News《澳华财经在线》报道：中资控股澳交所上市企业Orion Metals（ASX：ORM）周五发布公告披露，该公司已获得西澳矿产石油厅颁发的一块新矿权租地（E80/4556）的勘探许可证，该租地为今年获得的第四块租地。

该租地同样位于西澳中部的塔纳米沙漠区，且该租地将成为该公司旗下Killi Killi项目的一部分，目前该项目由6块租地组成。这6块租地隶属于该公司的全资子公司Rich Resources Investments。

E80/4556租地由22个分块组成，靠近Killi Killi项目其余5块租地，且位于ABM Resources旗下Buccaneer Porphyry和Old Pirate金矿床西北部偏西部约30公里处。

之前该公司发布的公告曾披露上述6块租地中E80/4179和E80/4029存在异常稀土元素和金矿化带。

Orion Metals主要从事稀土元素及金矿勘探，在西澳及昆州东北铀矿区附近拥有多个项目，西澳的Killi Killi项目为其旗舰资产。

2012年7月，北京琮霖集团子公司澳大利亚琮霖国际投资集团有限公司完成对ORM的场外收购，成为其最大股东，第二大股东为琮霖集团董事长岳琮霖先生，前两大股东合计持股57%。

周五该股收于0.075澳元。

Tags: ORM OrionMetals 矿权租地稀土金矿西澳昆州北京琮霖集团澳洲股市

相关阅读

: 【异动股】碳酸锂价格回升带来扩张契机 Patagonia Lithium (ASX:PL3) Formentera锂卤水项目钻探备受关注年内飙升逾2倍

Patagonia Lithium Ltd (ASX股票代码:PL3)位于阿根廷北部“锂三角”地带的Formentera/Cilon锂卤水项目钻探进展备受市场关注，今年以来PL3创出233.33%涨幅，尽管并无消息披露，周三再度飙涨28.57%，周涨幅扩大至63.64%。

: From Demonstration to Commercialisation: Calix’s Industrial Decarbonisation Platform Accelerates Execution

Australian clean technology company Calix Limited (ASX: CXL) has released the first company newsletter of 2026. Managing Director and Chief Executive Officer Phil Hodgson said the company’s industrial decarbonisation platform technology is progressing from demonstration toward commercial execution, supported by advancing projects, growing revenues and disciplined cash management.

: “重量级一周”开启！美股科技巨头财报集中来袭业绩牵动市场神经

美股即将迎来本轮财报季中最具分量的一周。多家市值居前的科技巨头将在本周集中公布最新季度业绩，其结果被市场视为左右主要股指短期走向的关键变量。

: 【1.27】今日财经时讯及重要市场资讯

美股即将迎来本轮财报季中最具分量的一周。多家市值居前的科技巨头将在本周集中公布最新季度业绩，其结果被市场视为左右主要股指短期走向的关键变量。

: Strong China Demand Fuels Compumedics (ASX: CMP) Neuro-Imaging Growth New A$4.9m MEG Order from Beijing Normal University Lifts Total Orders to A$25m

ASX-listed medical technology company Compumedics Limited (ASX: CMP) announced on November 10 that it has secured a new A$4.9 million magnetoencephalography (MEG) system order from Beijing Normal University, lifting total contracted MEG revenues to about A$25 million. The deal strengthens the company’s leadership in Asia’s fast-growing neuro-imaging market and highlights robust demand from China’s expanding neuroscience sector.

: ImpediMed (ASX: IPD) Reports Record Q3 Performance; Commercial Momentum Builds and Shares Rebound

5 May 2025 | ACB News – Sydney，ImpediMed Limited (ASX: IPD), a leading Australian medical technology company, has reported record results for the third quarter of FY2025, ended 31 March. Key financial metrics reached new highs as the company continues to scale deployment of its SOZO® digital health platform in the U.S.

: A new platform suggests a new dimension of China's development

At a time when the global economic structure is undergoing profound adjustments and technological changes are accelerating, China is breaking through with a higher level of institutional opening.

: Meta自研芯片浮出水面据称已进入小规模部署阶段

据媒体报道，两位消息人士透露，美国科技巨头Meta Platforms正在测试其首款用于训练人工智能系统的自研芯片。

免责声明：本网站信息仅供一般参考，不构成投资或财务建议。虽力求准确与完整，但不保证信息的准确性、完整性或时效性。投资有风险，决策前请咨询专业独立顾问。使用本网站即视为接受本免责声明。